Rote William E., Chief Officer of Travere Therapeutics TVTX, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $3.3M. The latest trade was on 05/06.

RE

RE

Rote William E.

Chief Research Officer

Company

Travere Therapeutics TVTX

First filing

23/01/26

Trades

37 trades

Buys / sales

0 / 16

12-month net buying

−$3.3M

Last trade

05/06

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	05/06	05/06	2,763 sh	$43.95	$121,433.85	−2.3%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	04/22	04/23	9,100 sh	$39.09	$355,719	−7.4%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	02/03	02/03	12,446 sh	$32.87	$409,100.02	−10.2%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	25/12/24	25/12/29	60,000 sh	$40.10	$2,406,000	−37.2%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	25/05/05	25/05/05	3,198 sh	$21.05	$67,317.9	−3.1%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	25/02/12	25/02/12	5,200 sh	$23.53	$122,356	−5.0%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	25/02/03	25/02/04	8,951 sh	$19.78	$177,050.78	−8.6%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	25/01/22	25/01/23	2,437 sh	$19.46	$47,424.02	−2.8%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	24/09/09	24/09/09	4,387 sh	$11.52	$50,538.24	−4.9%
Travere TherapeuticsTVTX	Open-market sale	24/02/01	24/02/02	4,764 sh2 trades	$8.71avg.	$41,491.62	−5.6%
Travere TherapeuticsTVTX	Open-market sale	24/01/23	24/01/25	2,062 sh	$8.96	$18,475.52	−3.3%
Travere TherapeuticsTVTX	Open-market sale	23/09/05	23/09/05	1,815 sh	$14.71	$26,698.65	−2.9%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	23/05/10	23/05/12	825 sh	$16.59	$13,686.75	−1.4%
Travere TherapeuticsTVTX	Open-market sale	23/02/01	23/02/02	2,590 sh	$22.25	$57,627.5	−4.1%
Travere TherapeuticsTVTX	Open-market sale	23/01/24	23/01/26	2,062 sh	$21.50	$44,333	−4.6%